No abstract available
Keywords:
Medical research; SARS-CoV-2; Therapeutics.
MeSH terms
-
Adenosine Monophosphate / analogs & derivatives
-
Adenosine Monophosphate / therapeutic use
-
Age Distribution
-
Age Factors
-
Aged
-
Aged, 80 and over
-
Alanine / analogs & derivatives
-
Alanine / therapeutic use
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Betacoronavirus / drug effects
-
Betacoronavirus / pathogenicity
-
COVID-19
-
COVID-19 Serotherapy
-
Coronavirus Infections / mortality*
-
Coronavirus Infections / prevention & control
-
Coronavirus Infections / therapy*
-
Coronavirus Infections / transmission
-
Dexamethasone / therapeutic use
-
Humans
-
Immunization, Passive
-
Intensive Care Units
-
Oxygen / administration & dosage
-
Oxygen / therapeutic use
-
Pandemics / prevention & control
-
Pneumonia, Viral / mortality*
-
Pneumonia, Viral / prevention & control
-
Pneumonia, Viral / therapy*
-
Pneumonia, Viral / transmission
-
Respiratory Distress Syndrome / complications
-
Respiratory Distress Syndrome / therapy
-
SARS-CoV-2
-
Time Factors
-
Ventilators, Mechanical
Substances
-
Antibodies, Monoclonal, Humanized
-
remdesivir
-
Adenosine Monophosphate
-
Dexamethasone
-
tocilizumab
-
Alanine
-
Oxygen